2022

Ramasamy, Karthik, Iqbal, Gulnaz, Brouwer, Richard, Stalker, Victoria, Akhtar, Salma, Varghese, Sherin, Lindsay, Jindriska, Schey, Stephen, Drayson, Mark and Dunn, Janet (2022) Bortezomib, Bendamustine and Dexamethasone vs Thalidomide, Bendamustine and Dexamethasone in Myeloma patients presenting with renal failure (OPTIMAL) : a randomised, multi-centre phase II trial. Blood Cancer Journal, 12 . 162. doi:10.1038/s41408-022-00758-7

Agbuduwe, Charles, Iqbal, Gulnaz, Cairns, David, Menzies, Tom, Dunn, Janet A., Gregory, Walter, Kaiser, Martin, Owen, Roger, Pawlyn, Charlotte, Child, J. Anthony, Davies, Faith, Morgan, Gareth J., Jackson, Graham H., Drayson, Mark T. and Basu, Supratik (2022) Clinical characteristics and outcomes of IgD myeloma : experience across UK national trials. Blood Advances, 6 (17). pp. 5113-5123. doi:10.1182/bloodadvances.2022007608

Trans-Tasman Radiation Oncology Group, De-ESCALaTE HPV Trial Group (Including: Rischin, D., Mehanna, H., Young, R. J., Bressel, M., Dunn, Janet A., Corry, J., Soni, P., Fulton-Lieuw, T., Iqbal, G., Kenny, L., Porceddu, S., Wratten, C., Robinson, M. and Solomon, B. J.). (2022) Prognostic stratification of HPV-associated oropharyngeal cancer based on CD103+ immune cell abundance in patients treated on TROG 12.01 and De-ESCALaTE randomized trials. Annals of Oncology, 33 (8). pp. 804-813. doi:10.1016/j.annonc.2022.04.074

The FAST MRI Study Group (Including:

). (2022) Evaluating the effectiveness of abbreviated breast MRI (abMRI) interpretation training for mammogram readers : a multi-centre study assessing diagnostic performance, using an enriched dataset. Breast Cancer Research, 24 (1). 55. doi:10.1186/s13058-022-01549-5

(2022) Multi-omic machine learning predictor of breast cancer therapy response. Nature, 601 . pp. 623-629. doi:10.1038/s41586-021-04278-5

I-SPY 2 TRIAL Consortium (Including:

). (2022) Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer : a multicentre pooled analysis of 5161 patients. Lancet Oncology, 23 (1). pp. 149-160. doi:10.1016/S1470-2045(21)00589-1

2021

FAST MRI Study Group (Including: Geach, R., Jones, L. I., Harding, S. A., Marshall, A. (Andrea), Taylor-Phillips, Sian, McKeown-Keegan, S. and Dunn, Janet A.). (2021) The potential utility of abbreviated breast MRI (FAST MRI) as a tool for breast cancer screening : a systematic review and meta-analysis. Clinical Radiology, 76 (2). 154.e11-154.e22. doi:10.1016/j.crad.2020.08.032

Earl, Helena M., Hiller, Louise, Dunn, Janet A., Macpherson, Iain, Rea, Daniel, Hughes-Davies, Luke, McAdam, Karen , Hall, Peter, Mansi, Janine , Wheatley, Duncan, Abraham, Jean, Caldas, Carlos, Gasson, Sophie, O'Riordan, Liz, Wilcox, Maggie, Miles, David , Cameron , David and Wardley, Andrew (2021) Optimising the duration of adjuvant trastuzumab in early breast cancer in the UK. Clinical Oncology, 33 (1). pp. 15-19. doi:10.1016/j.clon.2020.07.006

Goyal, Amit, Puri, Shama, Marshall, Andrea, Valassiadou, Kalliope, Hoosein, Moin M., Carmichael, Amtul R., Erdelyi, Gabriella, Sharma, Nisha, Dunn, Janet A. and York, Joanne (2021) A multicentre prospective feasibility study of carbon dye tattooing of biopsied axillary node and surgical localisation in breast cancer patients. Breast Cancer Research and Treatment, 185 . pp. 433-440. doi:10.1007/s10549-020-05961-3

2020

Kosmin, Michael, Padhani, Anwar R., Gogbashian, Andrew, Woolf, David, Ah-See, Mei-Lin, Ostler, Peter, Sutherland, Stephanie, Miles, David, Noble, Jillian, Koh, Dow-Mu, Marshall, Andrea, Dunn, Janet A. and Makris, Andreas (2020) Comparison of whole-body MRI, CT, and bone scintigraphy for response evaluation of cancer therapeutics in metastatic breast cancer to bone. Radiology, 297 (3). pp. 622-629. doi:10.1148/radiol.2020192683

OPTIMA Trial Management Group (Including: Bartlett, John M. S., Bayani, Jane, Kornaga, Elizabeth N., Danaher, Patrick, Crozier, Cheryl, Piper, Tammy, Yao, Cindy Q., Dunn, Janet A., Boutros, Paul C. and Stein, Robert C.). (2020) Computational approaches to support comparative analysis of multiparametric tests : modelling versus training. PLOS ONE, 15 (9). e0238593. doi:10.1371/journal.pone.0238593

(2020) Six versus 12 months’ adjuvant trastuzumab in patients with HER2-positive early breast cancer : the PERSEPHONE non-inferiority RCT. Health Technology Assessment, 24 (40). pp. 1-190. doi:10.3310/hta24400

Marshall, Andrea, Levine, Mark, Hill, Catherine, Hale, Danielle, Thirlwall, Jenny, Wilkie, Veronica, French, Karen, Kakkar, Ajay K., Lokare, Anand, Maraveyas, Anthony, Chapman, Oliver, Arif, Azra, Petrou, Stavros, Maredza, Mandy, Hobbs, FD Richard, Dunn, Janet A. and Young, Annie M. (2020) Treatment of cancer‐associated venous thromboembolism : 12‐month outcomes of the placebo versus rivaroxaban randomisation of the SELECT‐D Trial. (SELECT‐D: 12m). Journal of Thrombosis and Haemostasis, 18 (4). pp. 905-915. doi:10.1111/jth.14752

(2020) Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB) : a randomised, phase III, trial. Radiotherapy and Oncology, 142 . pp. 52-61. doi:10.1016/j.radonc.2019.10.014

Jones, David A., Mistry, Pankaj, Dalby, Matthew, Fulton-Lieuw, Tessa, Kong, Anthony H., Dunn, Janet A., Mehanna, Hisham M. and Gray, Alastair M. (2020) Concurrent cisplatin or cetuximab with radiotherapy for HPV-positive oropharyngeal cancer : Medical resource use, costs, and quality-adjusted survival from the De-ESCALaTE HPV trial. European Journal of Cancer Care, 124 . pp. 178-185. doi:10.1016/j.ejca.2019.10.025

(2020) Strategies to improve recruitment to a de-escalation trial : a mixed-methods study of the OPTIMA prelim trial in early breast cancer. Clinical Oncology . doi:10.1016/j.clon.2020.01.029

2019

Zarkar, A., Marshall, Andrea, Davies, A., Ford, D., James, N. D. and Dunn, Janet A. (2019) Cabazitaxel in platinum pre-treated patients with locally advanced or metastatic transitional cell carcinoma who developed disease progression after platinum based chemotherapy : results of the phase II CAB-B1 trial. International Journal of Cancer Research & Therapy, 4 (4).

Drayson, Mark T., Bowcock, Stella, Planche, Tim, Iqbal, Gulnaz, Pratt, Guy, Yong, Kwee, Wood, Jill, Raynes, Kerry, Higgins, Helen, Dawkins, Bryony, Meads, David, Hulme, Claire T., Whittaker, Anna C., Hawkey, Peter, Low, Eric and Dunn, Janet A. (2019) Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT. Health Technology Assessment, 23 (62). pp. 1-94. doi:10.3310/hta23620

(2019) Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM) : a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial. The Lancet. Oncology, 20 (12). pp. 1760-1772. doi:10.1016/S1470-2045(19)30506-6

FAST MRI Study Group (Including: Jones, Lyn I., Geach, Rebecca, Harding, Sam A., Foy, Christopher, Taylor, Victoria, Marshall, Andrea, Taylor-Phillips, Sian and Dunn, Janet A.). (2019) Can mammogram readers swiftly and effectively learn to interpret first post-contrast acquisition subtracted (FAST) MRI, a type of abbreviated breast MRI? : a single centre data-interpretation study. The British Journal of Radiology, 92 . 20190663. doi:10.1259/bjr.20190663

(2019) 6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE) : 4-year disease-free survival results of a randomised phase 3 non-inferiority trial. The Lancet, 393 (10191). pp. 2599-2612. doi:10.1016/S0140-6736(19)30650-6

Dunn, Janet A., Jefferson, Kieran, MacDonald, Donald, Iqbal, Gulnaz and Bland, Rosemary (2019) Low serum 25-hydroxyvitamin D is associated with increased bladder cancer risk: A systematic review and evidence of a potential mechanism. The Journal of Steroid Biochemistry and Molecular Biology, 188 . pp. 134-140. doi:10.1016/j.jsbmb.2019.01.002

(2019) Genome-wide association study of germline variants and breast cancer-specific mortality. British Journal of Cancer, 120 (6). pp. 647-657. doi:10.1038/s41416-019-0393-x

2018

(2018) Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV) : an open-label randomised controlled phase 3 trial. The Lancet, 393 (10166). pp. 51-60. doi:10.1016/S0140-6736(18)32752-1

Lipplaa, Astrid, Fernandes, Ricardo, Marshall, Andrea, Lorigan, Paul, Dunn, Janet A., Myers, Kevin A, Barker, Emily, Newton-Bishop, Julia, Middleton, Mark R. and Corrie, Pippa G. (2018) 25-hydroxyvitamin D serum levels in patients with high risk resected melanoma treated in an adjuvant bevacizumab trial. British Journal of Cancer, 119 . pp. 793-800. doi:10.1038/s41416-018-0179-6

Lin, Daniel J., McConkey, Christopher C., Nankivell, Paul, Dunn, Janet A. and Mehanna, Hisham (2018) The impact of institutional clinical trial recruitment versus hospital volume on survival outcomes of patients with head and neck cancer : an analysis of the PET-NECK trial outcomes, UKCRN portfolio, and Hospital Episode Statistics (HES) in England. Oral Oncology, 85 . pp. 40-43. doi:10.1016/j.oraloncology.2018.08.006

(2018) Adjuvant bevacizumab for melanoma patients at high risk of recurrence : survival analysis of the AVAST-M trial. Annals of Oncology, 29 (8). pp. 1843-1852. doi:10.1093/annonc/mdy229

Heaney, Jennifer L. J.,, Campbell, John P., Iqbal, Gulnaz, Cairns, David, Richter, Alex, Child, J. Anthony, Gregory, Walter, Jackson, Graham, Kaiser, Martin, Owen, Roger, Davies, Faith, Morgan, Gareth, Dunn, Janet A. and Drayson, Mark T. (2018) Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials. Leukemia, 32 . pp. 1727-1738. doi:10.1038/s41375-018-0163-4

Abdelrahim, Ameera, Balmer, Claire E., Jones, June, Mehanna, Hisham M. and Dunn, Janet A. (2018) Considerations for a head and neck smoking cessation support programme ; a qualitative study of the challenges in quitting smoking after treatment for head and neck cancer. European Journal of Oncology Nursing, 35 . pp. 54-61. doi:10.1016/j.ejon.2018.05.003

SELECT-D Collaborative Group (Including: Young, Annie M., Marshall, Andrea, Thirlwall, Jenny, Chapman, Oliver, Lokare, Anand, Hill, Catherine, Hale, Danielle, Dunn, Janet A., Lyman, Gary H., Hutchinson, Charles, MacCallum, Peter, Kakkar, Ajay, Hobbs, F. D. Richard, Petrou, Stavros, Dale, Jeremy, Poole, Christopher J., Maraveyas, Anthony and Levine, Mark). (2018) Comparison of an oral factor Xa inhibitor with low molecular weight heparin in cancer patients with venous thromboembolism : results of a randomized trial (SELECT-D). Journal of Clinical Oncology, 36 (20). pp. 2017-2023. doi:10.1200/JCO.2018.78.8034

Fackrell, D., Marshall, A. (Andrea)‏, Mistry, Pankaj, Dunn, Janet A., De Santis, Maria , Ford, D. and Zarkar, A. (2018) Radical treatment of muscle-invasive bladder cancer-are options equal? Journal of Radiation Oncology, 7 (2). pp. 181-186. doi:10.1007/s13566-018-0347-6

Taylor-Phillips, Sian, Jenkinson, David J., Stinton, Chris, Wallis, Matthew G., Dunn, Janet A. and Clarke, Aileen (2018) Double reading in breast cancer screening : cohort evaluation in the CO-OPS trial. Radiology, 287 (3). pp. 749-757. 171010. doi:10.1148/radiol.2018171010

Young, Annie M., Marshall, A. (Andrea)‏, Thirlwall, Jenny, Chapman, O., Lokare, A., Hills, Claire E., Hale, D., Dunn, Janet A., Kakkar, A., Levine, M. and Select-d Collaborative, Group (2018) Anticoagulation therapy in SELECTeD cancer patients at risk of recurrence of venous thromboembolism : results of the 'select-d' Pilot Trial. Thrombosis Research, 164 (Supplement 1). S194. doi:10.1016/j.thromres.2018.02.036

Chicca, I. J., Heaney, J. L. J., Iqbal, Gulnaz, Bowcock, S., Planche, T., Wood, J., Raynes, K., Hawkey, P., Pratt, G., Yong, K., Dunn, Janet A. and Drayson, M. T. (2018) Major changes in levels of regulatory cytokines and functional antibodies contribute to severe immunodeficiency of myeloma patients and persist at one year post diagnosis. Haematologica, 103 (Supplement 1). pp. 1-48. P02.

Bowcock, S., Atkin, C., Iqbal, Gulnaz, Yong, K., Pratt, G., Planche, T., Wood, J., Raynes, K., Hawkey, P., Dunn, Janet A., Drayson, M. and Co-Investigators, Teamm (2018) Does a long diagnostic pathway in myeloma lead to more advanced disease at presentation? An analysis from the TEAMM trial (Tackling EArly Morbidity and Mortality in Myeloma). British Journal of Haematology, 181 (Supplement 1). pp. 5-211. BSH18-PO-098 [pp 99]. doi:10.1111/bjh.15226

Bowcock, S., Planche, T., Iqbal, Gulnaz, Pratt, G., Yong, K., Wood, J., Raynes, K., Hawkey, P., Dunn, Janet A., Drayson, M. and Co-Investigators, Teamm (2018) Levofloxacin prophylaxis in newly diagnosed myeloma reduces febrile episodes and death without increasing healthcare associated infections : results from the TEAMM trial (Tackling EArly Morbidity and Mortality in Myeloma). British Journal of Haematology, 181 (Supplement 1). pp. 5-211. BSH18-OR-012 [pp16]. doi:10.1111/bjh.15226

Atkin, C., Drayson, M., Iqbal, Gulnaz, Yong, K., Pratt, G., Planche, T., Wood, J., Raynes, K., Higgins, Helen B., Dunn, Janet A. and Bowcock, S. (2018) Presenting symptoms of patients with multiple myeloma : data from the TEAMM (Tackling EArly Morbidity and Mortality in Myeloma) trial. British Journal of Haematology, 181 (Supplement 1). pp. 5-211. BSH18-PO-094 [pp 96]. doi:10.1111/bjh.15226

Hiller, Louise, Dunn, Janet A., Loi, Shrushma, Vallier, Anne-Laure, Howe, Donna L., Cameron, David A., Miles, David, Wardley, Andrew M. and Earl, Helena M. (2018) Adjuvant trastuzumab duration trials in HER2 positive breast cancer : what results would be practice-changing? Persephone investigator questionnaire prior to primary endpoint results. BMC Cancer, 18 . 391. doi:10.1186/s12885-018-4307-8

Lee, R. J., Gremel, G., Marshall, A. (Andrea)‏, Myers, K. A., Fisher, N., Dunn, Janet A., Dhomen, N., Corrie, P. G., Middleton, M. R., Lorigan, P. and Marais, R. (2018) Circulating tumor DNA predicts survival in patients with resected high risk stage II/III melanoma. Annals of Oncology, 29 (2). pp. 490-496. doi:10.1093/annonc/mdx717

(2018) OPTIMA : A prospective randomized trial to validate the predictive utility and cost-effectiveness of gene expression test-directed chemotherapy decisions in early breast cancer. Cancer Research, 78 (4). Abstract OT1-06-01. doi:10.1158/1538-7445.SABCS17-OT1-06-01

2017

Hall, P. S., Smith, A., Hulme, C., Vargas-Palacios, A., Makris, A., Hughes-Davies, L., Dunn, Janet A., Bartlett, J. M. S., Cameron, D. A., Marshall, A., Campbell, A., Macpherson, I. R., Dan, Rea, Francis, A., Earl, H., Morgan, A., Stein, R. C. and McCabe, C. (2017) Value of information analysis of multiparameter tests for chemotherapy in early breast cancer : the OPTIMA prelim trial. Value in Health, 20 (10). pp. 1311-1318. doi:10.1016/j.jval.2017.04.021

Smith, A. F., Hall, P. S., Hulme, C. T., Dunn, Janet A., McConkey, Christopher C., Rahman, J. K., McCabe, C. and Mehanna, H. (2017) Cost-effectiveness analysis of PET-CT-guided management for locally advanced head and neck cancer. European Journal of Cancer, 85 . pp. 6-14. doi:10.1016/j.ejca.2017.07.054

(2017) Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 negative early breast cancer : ARTemis Trial. Annals of Oncology, 28 (8). pp. 1817-1824. doi:10.1093/annonc/mdx173

Ali, H. R., Dariush, A., Thomas, J., Provenzano, E., Dunn, Janet A., Hiller, Louise, Vallier, A.-L., Abraham, J., Piper, T., Bartlett, J. M. S., Cameron, D. A., Hayward, L., Brenton, J. D., Pharoah, P. D. P., Irwin, M. J., Walton, N. A., Earl, H. M. and Caldas, C. (2017) Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer : secondary analysis of the ARTemis trial. Annals of Oncology, 28 (8). pp. 1832-1835. doi:10.1093/annonc/mdx266

Fenlon, D., Morgan, A., Khambaita, P., Mistry, Pankaj, Dunn, Janet A., Ah-See, M. L., Pennery, E. and Hunter, M. S. (2017) Management of hot flushes in UK breast cancer patients : clinician and patient perspectives. Journal of Psychosomatic Obstetrics & Gynecology, 38 (4). pp. 276-283. doi:10.1080/0167482X.2017.1350163

Mistry, Pankaj, Dunn, Janet A. and Marshall, A. (Andrea) (2017) A literature review of applied adaptive design methodology within the field of oncology in randomised controlled trials and a proposed extension to the CONSORT guidelines. BMC Medical Research Methodology, 17 (1). 108. doi:10.1186/s12874-017-0393-6

(2017) Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo) : final 10-year follow-up of an open-label, randomised, phase 3 trial. The Lancet Oncology, 18 (6). pp. 755-769. doi:10.1016/S1470-2045(17)30319-4

(2017) Central pathology review with two-stage quality assurance for pathological response after neoadjuvant chemotherapy in the ARTemis Trial. Modern Pathology, 30 (8). pp. 1069-1077. doi:10.1038/modpathol.2017.30

Taylor-Phillips, Sian, Jenkinson, David J., Wallis, Matthew, Dunn, Janet A. and Clarke, Aileen (2017) Pragmatic integrated randomised controlled trials in screening : experience from a trial in 1.2million women attending breast screening. Trials, 18 (Supplement 1). p. 200. O45 [pp 204]. doi:10.1186/s13063-017-1902-y

Dunn, Janet A., Marshall, A. (Andrea)‏, Ramirez, M., Evans, A. and Donnelly, P. (2017) Value of a sister observational cohort alongside a randomised controlled trial with an internal feasibility phase. Trials, 18 (Supplement 1). p. 1. P261 [pp 99]. doi:10.1186/s13063-017-1902-y

Mistry, Pankaj, Dunn, Janet A. and Marshall, A. (Andrea)‏ (2017) A literature review of the use of adaptive design methods in oncology trials. Trials, 18 (Supplement 1). p. 200. P106 [pp 40-41]. doi:10.1186/s13063-017-1902-y

Mehanna, H., McConkey, Christopher C., Rahman, J., Wong, W. L., Smith, A. F., Nutting, C., Hartley, A. G. J., Hall, P., Hulme, C., Patel, D., Von Zeidler, S. V., Robinson, M., Sanghera, B., Fresco, L. and Dunn, Janet A. (2017) PET-NECK : a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography-computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer. Health Technology Assessment, 21 (17). pp. 1-122. doi:10.3310/hta21170

OPTIMA Trial Management Group (Including: Pinder, S. E., Campbell, Amy, Bartlett, J. M. S., Marshall, A. (Andrea)‏, Allen, D., Falzon, M., Dunn, Janet A., Makris, A., Hughes-Davies, L. and Stein, R. C.). (2017) Discrepancies in central review re-testing of patients with ER-positive and HER2-negative breast cancer in the OPTIMA prelim randomised clinical trial. British Journal of Cancer, 116 . 859-863 . doi:10.1038/bjc.2017.28

Morgan, A., Ah-See, M. L., Hunter, M., Armes, J., Filshie, J., Turner, L., Morris, C., Flint, M., Dunn, Janet A., Pennery, E., Sassarini, J., Stanway, S., Noble, J., Andreia, F., Morgan, D., Khambhaita, P. and Fenlon, D. (2017) Comparing clinician and patient perspectives in the management of hot flushes in UK breast cancer patients. BJOG-an International Journal of Obstetrics and Gynaecology, 124 (Supplement 1). pp. 100-102. HP114. doi:10.1111/1471-0528.7_14572

Ford, H., Marshall, A., Blazeby, J. M., Bridgewater, J. A., Wadsley, J., Coxon, F. Y., Mansoor, W., Madhusudan, S., Falk, S., Middleton, G. W., Swinson, D., Chau, I., Thompson, J., Cunningham, D., Kareclas, P. and Dunn, Janet A. (2017) Cougar-02 : a randomized phase III study of docetaxel versus active symptom control in patients with relapsed esophago-gastric adenocarcinoma. Journal of Clinical Oncology, 31 (15). doi:10.1200/jco.2013.31.4_suppl.lba4

2016

Ali, H. Raza, Dariush, Aliakbar, Provenzano, Elena, Bardwell, Helen, Abraham, Jean E., Iddawela, Mahesh, Vallier, Anne-Laure, Hiller, Louise, Dunn, Janet A., Bowden, Sarah J., Hickish, Tamas, McAdam, Karen, Houston, Stephen, Irwin, Mike J., Pharoah, Paul D. P., Brenton, James D., Walton, Nicholas A., Earl, Helena M. and Caldas, Carlos (2016) Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer. Breast Cancer Research, 18 (1). 21. doi:10.1186/s13058-016-0682-8

Earl, Helena M, Vallier, Anne-Laure, Dunn, Janet A., Loi, Shrushma, Ogburn, Emma, McAdam, Karen, Hughes-Davies, Luke, Harnett, Adrian, Abraham, Jean, Wardley, Andrew, Cameron, David A, Miles, David, Gounaris, Ioannis, Plummer, Chris and Hiller, Louise (2016) Trastuzumab-associated cardiac events in the Persephone trial. British Journal of Cancer, 115 (12). pp. 1462-1470. doi:10.1038/bjc.2016.357

Smith, A. F., Hall, P. S., Hulme, Charles, McConkey, Christopher C., Dunn, Janet A., Rahman, J. and Mehanna, H. (2016) PET-CT surveillance for advanced head and neck cancer : a cost-effective alternative to planned neck dissection? Annals of Oncology, 27 (Supplement 6). 952PD. doi:10.1093/annonc/mdw376.05

Wong, W. L., Dunn, Janet A. and Mehanna, H. (2016) The role of PET CT in the management of advanced nodal head neck cancer post chemoradiotherapy. Translational Cancer Research, 5 (Supplement 4). S932-S932. doi:10.21037/tcr.2016.10.89

Hartley, A., Fong, C., Sanghera, P., Wong, W. L., McConkey, Christopher C., Rahman, J., Nutting, C. M., Al-Booz, H., Robinson, M., Junor, E., Rizwanullah, M., Dunn, Janet A. and Mehanna, H. (2016) Radiation therapy variation in the Randomized Phase 3 Positron Emission Tomography Neck Study. International Journal of Radiation Oncology Biology Physics, 96 (2). S117. doi:10.1016/j.ijrobp.2016.06.285

(2016) Comparing breast cancer multiparameter tests in the OPTIMA Prelim Trial : no test is more equal than the others. Journal of the National Cancer Institute, 108 (9). djw050. doi:10.1093/jnci/djw050

Mehanna, H., Wong, W. L. and Dunn, Janet A. (2016) Management of Advanced Head and Neck Cancer REPLY. New England Journal of Medicine, 375 (5). pp. 492-493. doi:10.1056/NEJMc1606211

Dorling, L, Kar, Siddhartha, Michailidou, Kyriaki, Hiller, Louise, Vallier, Anne-Laure, Ingle, Susan, Hardy, Richard, Bowden, Sarah J., Dunn, Janet A., Twelves, Chris, Poole, Christopher J., Caldas, Carlos, Earl, Helena M., Pharoah, Paul D. P. and Abraham, Jean E. (2016) The relationship between common genetic markers of breast cancer risk and chemotherapy-induced toxicity : a case-control study. PLoS One, 11 (7). e0158984. doi:10.1371/journal.pone.0158984

(2016) A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease. Science Translational Medicine, 8 (341). 341ra76. doi:10.1126/scitranslmed.aad3744

Taylor-Phillips, Sian, Wallis, Matthew G., Jenkinson, David J., Adekanmbi, Victor, Parsons, Helen, Dunn, Janet A., Stallard, Nigel, Szczepura, Ala, Gates, Simon, Kearins, Olive, Duncan, Alison, Hudson, Sue and Clarke, Aileen (2016) Effect of using the same vs different order for second readings of screening mammograms on rates of breast cancer detection : a randomized clinical trial. JAMA: The Journal of the American Medical Association, 315 (18). pp. 1956-1965. doi:10.1001/jama.2016.5257

(2016) OPTIMA (Optimal Personalised Treatment of early breast cancer using Multi-parameter Analysis) : A prospective trial to validate the predictive utility and cost-effectiveness of gene expression test-directed chemotherapy decisions. European Journal of Surgical Oncology (EJSO), 42 (5). S9-S10. doi:10.1016/j.ejso.2016.02.048

Young, Annie M., Phillips, Jennifer, Hancocks, N. Helen, Hill, Catherine, Joshi, Neya, Marshall, A. (Andrea)‏, Grumett, Joanne, Dunn, Janet A., Lokare, A. and Chapman, O. (2016) OC-11 - Anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism. Thrombosis Research, 140 . S172-S173. doi:10.1016/S0049-3848(16)30128-1

Mehanna, Hisham, Wong, Wai-Lup, McConkey, Christopher C., Rahman, Joy K., Robinson, Max, Hartley, Andrew G.J., Nutting, Christopher, Powell, Ned, Al-Booz, Hoda, Robinson, Martin, Junor, Elizabeth, Rizwanullah, Mohammed, von Zeidler, Sandra L. V., Wieshmann, Hulya, Hulme, Claire, Smith, Alison F., Hall, Peter and Dunn, Janet A. (2016) PET-CT surveillance versus neck dissection in advanced head and neck cancer. New England Journal Of Medicine, 374 (15). pp. 1444-1454. doi:10.1056/NEJMoa1514493

Janowitz, Tobias, Thuss-Patience, Peter, Marshall, A. (Andrea)‏, Kang, Jung Hun, Connell, Claire, Cook, Natalie, Dunn, Janet A., Park, Se Hoon and Ford, Hugo (2016) Chemotherapy vs supportive care alone for relapsed gastric, gastroesophageal junction, and oesophageal adenocarcinoma : a meta-analysis of patient-level data. British Journal of Cancer, 114 (4). pp. 381-387. doi:10.1038/bjc.2015.452

(2016) NEO-EXCEL phase III neoadjuvant trial of pre-operative exemestane or letrozole plus /- celecoxib in the treatment of ER positive postmenopausal early breast cancer. Cancer Research, 76 . p. 2. doi:10.1158/1538-7445.SABCS15-PD2-02

Stein, Robert C., Dunn, Janet A., Bartlett, John M. S., Campbell, Amy, Marshall, A. (Andrea)‏, Hall, Peter, Rooshenas, Leila, Morgan, Adrienne, Poole, Christopher, Pinder, Sarah E., Cameron, David A., Stallard, Nigel, Donovan, Jenny L., McCabe, Christopher, Hughes-Davies, Luke and Makris, Andreas (2016) R : OPTIMA prelim : a randomised feasibility study of personalised care in the treatment of women with early breast cancer. Health Technology Assessment, 20 (10). pp. 1-202. doi:10.3310/hta20100

Mehanna, H., Franklin, N., Compton, N., Robinson, M., Powell, N., Biswas-Baldwin, N., Paleri, V., Hartley, A., Fresco, L., Al-Booz, H., Junor, E., El-Hariry, I., Roberts, S., Harrington, K., Ang, K. K., Dunn, Janet A. and Woodman, C. (2016) Geographic variation in human papillomavirus-related oropharyngeal cancer : data from 4 multinational randomized trials. Head and Neck, 38 . E1863-E1869. doi:10.1002/hed.24336

Meads, David M., Marshall, A. (Andrea)‏, Hulme, Claire T., Dunn, Janet A. and Ford, Hugo E. R. (2016) The cost effectiveness of docetaxel and active symptom control versus active symptom control alone for refractory oesophagogastric adenocarcinoma : economic analysis of the COUGAR-02 trial. PharmacoEconomics, 34 (1). pp. 33-42. doi:10.1007/s40273-015-0324-5

Mehanna, H., Wong, W. L. and Dunn, Janet A. (2016) Management of advanced nodal disease in patients treated with primary chemoradiotherapy. Current Opinion in Oncology, 28 (3). pp. 201-204. doi:10.1097/CCO.0000000000000283

2015

Abraham, Jean E., Hiller, Louise, Dorling, Leila, Vallier, Anne-Laure, Dunn, Janet A., Bowden, Sarah, Ingle, Susan, Jones, Linda, Hardy, Richard, Twelves, Christopher, Poole, Christopher J., Pharoah, Paul D. P., Caldas, Carlos and Earl, Helena M. (2015) A nested cohort study of 6,248 early breast cancer patients treated in neoadjuvant and adjuvant chemotherapy trials investigating the prognostic value of chemotherapy-related toxicities. BMC Medicine, 13 (1). 306. doi:10.1186/s12916-015-0547-5

Dunn, Janet A., Marshall, A. (Andrea)‏, Campbell, Amy, Cameron, D., Earl, H., Macpherson, I., Poole, C., Rea, D., Francis, A., Harmer, V., Morgan, A., Stallard, Nigel, Makris, A., Hughes-Davies, L. and Stein, R. (2015) Practicalities of using an adaptive design for decision making within the optima trial : optimal personalized treatment of early breast cancer using multi-parameter tests. Trials, 16 (Supplement 2). P212. doi:10.1186/1745-6215-16-S2-P212

Mistry, Pankaj, Hiller, Louise, Iqbal, Gulnaz and Dunn, Janet A. (2015) Under-representation of male patients in breast cancer studies. Trials, 16 (Supplement 2). P110. doi:10.1186/1745-6215-16-S2-P110

Dunn, Janet A., Harris, B., Iqbal, Gulnaz, Wood, J., Mistry, Pankaj, O'Beirne-Elliman, J., Bowcock, S. and Drayson, M. (2015) Use of patient diaries in conjunction with standard reporting methods : duplication of data or a valuable resource? Trials, 16 (Supplement 2). P183.

Hall, P., Smith, A., Hulme, C., Vargas-Palacios, A., Dunn, Janet A., Marshall, A. (Andrea)‏, Bartlett, J., Stein, R., Cameron, D. and McCabe, C. (2015) The use of early decision modelling and value of information analysis in an adaptive trial design : results from the OPTIMA preliminary study. Trials, 16 (Supplement 2). O19. doi:10.1186/1745-6215-16-S2-O19

Huish, S. A., Fletcher, S., Dunn, Janet A., Hewison, M. and Bland, R. (2015) Prevalence and treatment of hypovitaminosis D in the haemodialysis population of Coventry. Journal of Steroid Biochemistry and Molecular Biology, 164 . pp. 214-217. doi:10.1016/j.jsbmb.2016.02.009

Hiller, Louise, Marshall, A. (Andrea)‏ and Dunn, Janet A. (2015) Assessing violations of the proportional hazards assumption in Cox regression : does the chosen method matter? Trials, 16 (Supplement 2). P134. doi:10.1186/1745-6215-16-S2-P134

Mehanna, H., Wong, W. L., McConkey, Christopher C., Rahman, J. K., Robinson, M., Hartley, A., Nutting, C., Powell, N., Al-Booz, H., Robinson, M., Junor, E., Hulme, C., Smith, A. F., Hall, P. and Dunn, Janet A. (2015) Differences in the quality of life (QoL) and functional outcomes of treatment between HPV associated (HPV plus ) and HPV-patients receiving primary chemoradiotherapy in PET-NECK - a multi-centre randomized phase III controlled trial (RCT) comparing PETCT guided active surveillance with planned neck dissection (ND) for locally advanced (N2/N3) nodal metastases (LANM) in patients with head and neck squamous cell cancer (HNC) treated with primary radical chemoradiotherapy (CRT). European Journal of Cancer, 51 (Supplement 3). S715. doi:10.1016/S0959-8049(16)31936-0

(2015) Results of the OPTIMA (Optimal Personalized Treatment of early breast cancer usIng Multi-parameter Analysis) prelim study. European Journal of Cancer Care, 51 (Supplement 3). S268. doi:10.1016/S0959-8049(16)30762-6

Balmer, Claire E., Griffiths, Frances and Dunn, Janet A. (2015) A 'new normal' : exploring the disruption of a poor prognostic cancer diagnosis using interviews and participant-produced photographs. Health, 19 (5). pp. 451-472. doi:10.1177/1363459314554319

Bryan, R. T., Evans, T., Dunn, Janet A., Iqbal, Gulnaz, Bathers, S., Collins, S. I., James, Nicholas D., Catto, J. W. F. and Wallace, D. M. A. (2015) A comparative analysis of the influence of gender, pathway delays, and risk factor exposures on the long-term outcomes of bladder cancer. European Urology Focus, 1 (1). pp. 82-89. doi:10.1016/j.euf.2015.01.001

Balmer, Claire E., Griffiths, Frances and Dunn, Janet A. (2015) A review of the issues and challenges involved in using participant-produced photographs in nursing research. Journal of Advanced Nursing, 71 (7). pp. 1726-1737. doi:10.1111/jan.12627

Balmer, Claire E., Griffiths, Frances and Dunn, Janet A. (2015) A review of the issues and challenges involved in using participant-produced photographs in nursing research. Journal of Advanced Nursing, 71 (7). pp. 1726-1737. doi:10.1111/jan.12627

(2015) Making randomised trials more efficient : report of the first meeting to discuss the Trial Forge platform. Trials, 16 (1). pp. 1-9. 776. doi:10.1186/s13063-015-0776-0

(2015) Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis) : an open-label, randomised, phase 3 trial. The Lancet Oncology, 16 (6). pp. 656-666. doi:10.1016/S1470-2045(15)70137-3

Young, Annie M., Phillips, Jessica M., Hancocks, H., Marshall, A. (Andrea)‏, Grumett, J., Dunn, Janet A. and Chapman, Oliver (2015) Anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism. Journal of Clinical Oncology, 33 (15). p. 1.

Smith, A. F., Hall, P., Hulme, C., Dunn, Janet A., Rahman, J. K., McConkey, Christopher C. and Mehanna, H. (2015) Is PET-CT guided management for patients with locally advanced head and neck squamous cell cancer (HNSCC) cost-effective? Results from a UK non-inferiority phase III randomized trial. Journal of Clinical Oncology, 33 (15). p. 6010. doi:10.1200/jco.2015.33.15_suppl.6010

Mehanna, H. M., Wong, W. L., McConkey, Christopher C., Rahman, J. K., Robinson, M., Hartley, A. G. J., Nutting, C., Powell, N., Al-Booz, H., Robinson, M., Junor, E., Hulme, C., Smith, A. F., Hall, P. and Dunn, Janet A. (2015) PET-NECK: A multi-centre, randomized, phase III, controlled trial (RCT) comparing PETCT guided active surveillance with planned neck dissection (ND) for locally advanced (N2/N3) nodal metastases (LANM) in patients with head and neck squamous cell cancer (HNSCC) treated with primary radical chemoradiotherapy (CRT). Journal of Clinical Oncology, 33 (15). p. 6009. doi:10.1200/jco.2015.33.15_suppl.6009

Bartlett, J. M. S., McConkey, Christopher C., Munro, A. F., Desmedt, C., Dunn, Janet A., Larsimont, D., O'Malley, F. P., Cameron, D. A., Earl, H., Poole, Christopher J., Shepherd, L. E., Cardoso, F., Jensen, M., Caldas, C., Twelves, C. J., Rea, D. W., Ejlertsen, B., Di Leo, A. and Pritchard, K. I. (2015) Predicting anthracycline benefit : TOP2A and CEP17-not only but also. European Journal of Cancer Care, 33 (15). pp. 1680-1687. doi:10.1200/JCO.2013.54.7869

Earl, Helena, Provenzano, Elena, Abraham, Jean, Dunn, Janet A., Vallier, Anne-Laure, Gounaris, Ioannis and Hiller, Louise (2015) Neoadjuvant trials in early breast cancer : pathological response at surgery and correlation to longer term outcomes – what does it all mean? BMC Medicine, 13 (1). 234. doi:10.1186/s12916-015-0472-7

Bartlett, J. M. S., Stein, R. C., Bayani, J., Marshall, A. (Andrea)‏, Dunn, Janet A., Campbell, A. F., Cunningham, C., Sobol, M., Hall, P., Rooshenas, L., Morgan, A., Poole, Christopher J., Pinder, S. E., Cameron, D. A., Stallard, Nigel, Donovan, J., McCabe, C., Hughes-Davies, L. and Makris, A. (2015) Comparison of multiparameter tests in the UK OPTIMA-Prelim trial. Cancer Research, 75 (Supplement 9). P4-11-07 . doi:10.1158/1538-7445.SABCS14-P4-11-07

(2015) Common germline polymorphisms associated with breast cancer-specific survival. Breast Cancer Research, 17 (1). 58. doi:10.1186/s13058-015-0570-7

(2015) Identification of Novel Genetic Markers of Breast Cancer Survival. JNCI Journal of the National Cancer Institute, 107 (5). djv081. doi:10.1093/jnci/djv081

(2015) FKBPL : a marker of good prognosis in breast cancer. Oncotarget, 6 (14). pp. 12209-12223. doi:10.18632/oncotarget.3528

Ali, H. R., Glont, S.- E., Blows, F. M., Provenzano, E., Dawson, S.- J., Liu, B., Hiller, Louise, Dunn, Janet A., Poole, C. J., Bowden, S., Earl, H. M., Pharoah, P. D. P. and Caldas, C. (2015) PD-L1 protein expression in breast cancer is rare, enriched in basal-like tumours and associated with infiltrating lymphocytes. Annals of Oncology, 26 (7). doi:10.1093/annonc/mdv192

2014

Meads, D. M., McCabe, C., Hulme, C. T., Edlin, R., Kharroubi, S. A., Browne, C., Ford, H., Dunn, Janet A. and Marshall, A. (2014) Cost-utility of cancer therapies - the 'cost' of different utility generation strategies. In: ISPOR 17th Annual European Congress, Amsterdam, The Netherlands, 08 - 12 Nov 2014 . Published in: Value in Health: The Journal of The International Society for Pharmacoeconomic and Outcomes Research, 17 (7). A327. ISSN 1098-3015. doi:10.1016/j.jval.2014.08.591

Dunn, Janet A., Donnelly, P. K., Marshall, A. (Andrea)‏, Wilcox, M., Watson, E., Young, Annie M., Balmer, Claire E., Ramirez, M., Hartup, S., Maxwell, A.J. and Evans, A. J. (2014) Follow-up in early breast cancer — a surgical and radiological perceptive. Clinical Oncology, Volume 26 (Number 10). pp. 625-629. doi:10.1016/j.clon.2014.06.015

Balmer, Claire E., Griffiths, Frances and Dunn, Janet A. (2014) A qualitative systematic review exploring lay understanding of cancer by adults without a cancer diagnosis. Journal of Advanced Nursing, 70 ( 8). pp. 1688-1701. doi:10.1111/jan.12342

(2014) Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients. Annals of Oncology, 25 (8). pp. 1536-1543. doi:10.1093/annonc/mdu191

(2014) ARTemis: A randomised trial of bevacizumab with neoadjuvant chemotherapy (NACT) for patients with HER2-negative early breast cancer-Primary endpoint, pathological complete response (pCR). Journal of Clinical Oncology, 32 (15). p. 1014. doi:10.1200/jco.2014.32.15_suppl.1014

Hiller, Louise, Vallier, A. L., Ogburn, E., Wardley, A. M., Cameron, D. A., Miles, D., Dunn, Janet A. and Earl, H. M. (2014) Cardiology monitoring substudy in the PERSEPHONE trial : 6 versus 12 months of trastuzumab. Journal of Clinical Oncology, 32 (15). p. 1. doi:10.1200/jco.2014.32.15_suppl.552

Young, Annie M., Dunn, Janet A., Chapman, O., Grumett, J., Marshall, A. , Phillips, J. and Lokare, A. (2014) SELECT-D : anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism. Journal of Clinical Oncology, 32 (15). doi:10.1200/jco.2014.32.15_suppl.tps9661

Young, Annie M., Phillips, J., Marshall, A., Grumett, J., Dunn, Janet A., Lowe, S., Chapman, O. and Lokare, A. (2014) Anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism. In: 7th ITHIC. Published in: Thrombosis Research, 133 (Supplement 2). S220-S220. ISSN 0049-3848. doi:10.1016/S0049-3848(14)50032-1

(2014) Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M) : preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study. The Lancet Oncology, Volume 15 (Number 6). pp. 620-630. doi:10.1016/S1470-2045(14)70110-X

Abraham, J. E., Guo, Q., Dorling, L., Tyrer, J., Ingle, S., Hardy, R., Vallier, A.-L., Hiller, Louise, Burns, R., Jones, L., Bowden, S. J., Dunn, Janet A., Poole, C. J., Caldas, C., Pharoah, P. P. D. and Earl, Helena M. (2014) Replication of genetic polymorphisms reported to be associated with taxane-related sensory neuropathy in patients with early breast cancer treated with paclitaxel. Clinical Cancer Research, Volume 20 (Number 9). pp. 2466-2475. doi:10.1158/1078-0432.CCR-13-3232

Molyneux, Elizabeth, Merrick, Blair, Khanim, Farhat L., Banda, Kondwani, Dunn, Janet A., Iqbal, Gulnaz, Bunce, Christopher M. and Drayson, Mark T. (2014) Bezafibrate and medroxyprogesterone acetate in resistant and relapsed endemic Burkitt lymphoma in Malawi ; an open-label, single-arm, phase 2 study (ISRCTN34303497). British Journal of Haematology, Volume 164 (Number 6). pp. 888-890. doi:10.1111/bjh.12681

Ah-See, M., Coles, C., Fenlon, D., Pennery, E., Dunn, Janet A. and Morgan, A. (2014) The current management of vasomotor symptoms in breast cancer patients in the UK : clinician versus patient perspective. NCRI Breast CSG Working Party on Symptom Management (Vasomotor). European Journal of Cancer, 50 . S88-S89.

(2014) Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo) : an open-label, 2×2 factorial randomised phase 3 trial. The Lancet Oncology, Volume 15 (Number 2). pp. 201-212. doi:10.1016/S1470-2045(13)70554-0

Wason, J., Marshall, A. (Andrea)‏, Dunn, Janet A., Stein, R. C. and Stallard, Nigel (2014) Adaptive designs for clinical trials assessing biomarker-guided treatment strategies. British Journal of Cancer, Volume 110 (Number 8). pp. 1950-1957. doi:10.1038/bjc.2014.156

Taylor-Phillips, Sian, Wallis, Matthew G., Parsons, Helen, Dunn, Janet A., Stallard, Nigel, Campbell, Helen, Sellars, Sarah, Szczepura, Ala, Gates, Simon and Clarke, Aileen (2014) Changing case order to optimise patterns of performance in mammography screening (CO-OPS) : study protocol for a randomized controlled trial. Trials, Volume 15 . Article number 17. doi:10.1186/1745-6215-15-17

Ford, Hugo, Marshall, A. (Andrea), Bridgewater, John A., Janowitz, Tobias, Coxon, Fareeda Y., Wadsley, Jonathan, Mansoor, Wasat, Fyfe, David, Madhusudan, Srinivasan, Middleton, Gary W., Swinson, Daniel, Falk, Stephen, Chau, Ian, Cunningham, David, Kareclas, Paula, Cook, Natalie, Blazeby, Jane M. and Dunn, Janet A. (2014) Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02) : an open-label, phase 3 randomised controlled trial. The Lancet Oncology, Volume 15 (Number 1). pp. 78-86. doi:10.1016/S1470-2045(13)70549-7

2013

Earl, H. M., Vallier, A. L., Ogburn-Storey, E., Cameron, D. A., Wardley, A. M., Miles, D., Loi, S., Hiller, Louise, Higgins, H. B. and Dunn, Janet A. (2013) PERSEPHONE : duration of trastuzumab with chemotherapy in women with HER-2+ve early breast cancer. Cancer Research, 73 (Supplement 24). OT1-1-08. doi:10.1158/0008-5472.SABCS13-OT1-1-08

Morgan, A., Fenlon, D., Coles, C., Armstrong, A., Randle, K., Thompson, A. and Dunn, Janet A. (2013) Is it me or is it hot in here? Hot flushes (or flashes) : an unmet need. UK NCRI breast clinical studies group working party on symptom management (vasomotor). Cancer Research, 73 (24). p. 2. doi:10.1158/0008-5472.SABCS13-P3-08-09

McCaul, James A., Cymerman, James A., Hislop, Stuart, McConkey, Christopher C., McMahon, Jeremy, Mehanna, Hisham M., Shaw, Richard, Sutton, David N. and Dunn, Janet A. (2013) LIHNCS - Lugol's iodine in head and neck cancer surgery : a multicentre, randomised controlled trial assessing the effectiveness of Lugol’s iodine to assist excision of moderate dysplasia, severe dysplasia and carcinoma in situ at mucosal resection margins of oral and oropharyngeal squamous cell carcinoma : study protocol for a randomised controlled trial. Trials, Volume 14 (Number 1). Article number 310. doi:10.1186/1745-6215-14-310

Bradley, A., Marshall, A., Stonehewer, L., Reaper, L., Parker, K., Bevan-Smith, E., Jordan, C., Gillies, J., Agostini, P., Bishay, E., Kalkat, M., Steyn, R., Rajesh, P., Dunn, Janet A. and Naidu, B. (2013) Pulmonary rehabilitation programme for patients undergoing curative lung cancer surgery. European Journal of Cardio-thoracic Surgery, 44 (4). e266-e271. doi:10.1093/ejcts/ezt381

Bryan, Richard T., Zeegers, Maurice P., van Roekel, Eline H., Bird, Deborah, Grant, Margaret R., Dunn, Janet A., Bathers, Sarah, Iqbal, Gulnaz, Khan, Humera S., Collins, Stuart I., Howman, Andrew, Deshmukh, Nayneeta S., James, Nicholas D., Cheng, Kar Keung and Wallace, D. Michael A. (2013) A comparison of patient and tumour characteristics in two UK bladder cancer cohorts separated by 20 years. BJU International, Volume 112 (Number 2). pp. 169-175. doi:10.1111/bju.12032

(2013) Adjuvant bevacizumab as treatment for melanoma patients at high risk of recurrence : preplanned interim results for the AVAST-M trial. Journal of Clinical Oncology, 31 (18). doi:10.1200/jco.2013.31.18_suppl.lba9000

(2013) AVAST-M: Adjuvant bevacizumab as treatment for melanoma patients at high risk of recurrence. Journal of Clinical Oncology, 31 (15). doi:10.1200/jco.2013.31.15_suppl.lba9000

(2013) Neo-tAnGo science : a translational study of PAM 50 sub-typing in sequential fresh tissue samples during neoadjuvant chemotherapy. Journal of Clinical Oncology, 31 (15). 1015. doi:10.1200/jco.2013.31.15_suppl.1015

Earl, H. M., Cameron, D. A., Miles, D., Wardley, A. M., Ogburn, E., Vallier, A. L., Loi, S., Higgins, H. B., Hiller, Louise and Dunn, Janet A. (2013) PERSEPHONE : duration of trastuzumab with chemotherapy in women with HER2-positive early breast cancer-six versus twelve months. Journal of Clinical Oncology, 31 (15). p. 1. doi:10.1200/jco.2014.32.15_suppl.tps656

McCaul, J. A., Cymerman, J., Sutton, D. N., Shaw, R. J., Hislop, S., Adamson, J. and Dunn, Janet A. (2013) Feasibility and surgeon acceptability of visualisation with Lugol's iodine (VILI) in the lihncs trial. Oral Oncology, 49 . S35-S35. doi:10.1016/j.oraloncology.2013.03.085

McCaul, J. A., Pendrill, A., Quantrill, J., Mehanna, H., McConkey, Christopher C. and Dunn, Janet A. (2013) LIHNCS trial (Lugol's iodine in head and neck cancer surgery) : Interim recruitment and data report. Oral Oncology, 49 . S37-S37. doi:10.1016/j.oraloncology.2013.03.088

Ali, Alaa M., Provenzano, Elena, Bartlett, John M. S., Abraham, Jean, Driver, Kristy, Munro, Alison F., Twelves, Chris, Poole, Christopher J., Hiller, Louise, Dunn, Janet A., Earl, Helena M., Caldas, Carlos and Pharoah, Paul D. (2013) Prognosis of early breast cancer by immunohistochemistry defined intrinsic sub-types in patients treated with adjuvant chemotherapy in the NEAT/BR9601 trial. International Journal of Cancer, Volume 133 (Number 6). pp. 1470-1478. doi:10.1002/ijc.28150

Ford, H., Marshall, A. (Andrea)‏, Wadsley, J., Coxon, F. Y., Mansoor, W., Bridgwater, J. A., Madhusudan, S., Falk, S., Middleton, G. W., Swinson, D., Chau, I., Thompson, J., Blazeby, J. M., Cunningham, D., Kareclas, P. and Dunn, Janet A. (2013) COUGAR-02 : a randomized phase 111 study of docetaxel versus active symptom control in advanced esophagogastric adenocarcinoma. Journal of Clinical Oncology, 31 (4). doi:10.1200/jco.2013.31.4_suppl.lba4

(2013) Selecting breast cancer patients for chemotherapy : the opening of the UK OPTIMA trial. Clinical Oncology, Volume 25 (Number 2). pp. 109-116. doi:10.1016/j.clon.2012.10.005

Provenzano, E., Vallier, A. -L., Champ, R., Walland, K., Bowden, S. (Sarah), Grier, Anna, Fenwick, Nicola, Abraham, J. (Janet), Iddawela, M., Caldas, C., Hiller, Louise, Dunn, Janet A. and Earl, Helena M. (2013) A central review of histopathology reports after breast cancer neoadjuvant chemotherapy in the neo-tango trial. British Journal of Cancer, Volume 108 (Number 4). pp. 866-872. doi:10.1038/bjc.2012.547

2012

Iqbal, Gulnaz, Johnson, Mark R. D., Szczepura, Ala, Gumber, Anil, Wilson, Sue and Dunn, Janet A. (2012) Ethnicity data collection in the UK: The healthcare professional's perspective. Diversity and equality in health and care, 9 (4). pp. 281-290.

Earl, H. M., Cameron, D. A., Miles, D., Wardley, A. M., Ogburn, E. R. M., Vallier, A. L., Loi, S., Higgins, H. B., Hiller, L. and Dunn, Janet A. (2012) PERSEPHONE : duration of trastuzumab with chemotherapy in women with HER2 positive early breast cancer. Cancer Research, 72 (24). p. 1. doi:10.1158/0008-5472.SABCS12-OT1-1-03

Nankivell, Paul, Dunn, Janet A., Langman, Michael J. and Mehanna, Hisham M. (2012) Feasibility of recruitment to an oral dysplasia trial in the United Kingdom. Head & Neck Oncology, Volume 4 (Number 1). Article number 40. doi:10.1186/1758-3284-4-40

Taggart, Frances M., Donnelly, Peter K. and Dunn, Janet A. (2012) Options for early breast cancer follow-up in primary and secondary care : a systematic review. BMC Cancer, Vol.12 (No.1). p. 238. doi:10.1186/1471-2407-12-238

Earl, H. M., Blenkinsop, C., Grybowicz, L., Vallier, A. L., Cameron, D. A., Bartlett, J. M. S., Murray, N., Caldas, C., Thomas, J., Dunn, Janet A., Higgins, H. B., Hiller, L. and Hayward, L. (2012) ARTemis trial - randomised trial with neo-adjuvant chemotherapy for patients with early breast cancer. Journal of Clinical Oncology, 30 (15). p. 1. doi:10.1200/jco.2012.30.15_suppl.tps1144

Dunn, Janet A., Kulkarni, R., Gouldesbrough, D., Mehanna, H., McMahon, J. M., Shaw, R. and McCaul, J. A. (2012) LIHNCS trial : Lugol's iodine in head and neck cancer surgery. Journal of Clinical Oncology, 30 (15).

Stein, R., Makris, A., Hughes-Davies, L., Dunn, Janet A., Bartlett, J. M. S., Donovan, J., McCabe, C., Cameron, D. A., Canney, P., Earl, H. M., Francis, A., Morgan, A., Pinder, S., Rea, D., Poole, C. J., Hall, P., Hiller, L., Stallard, Nigel and Higgins, H. B. (2012) OPTIMA prelim : optimal personalized treatment of early breast cancer using multiparameter analysis : preliminary study. Journal of Clinical Oncology, 30 (15).

Earl, H. M., Cameron, D. A., Miles, D., Wardley, A. M., Ogburn, E., Vallier, A. L., Loi, S., Higgins, H. B., Hiller, L. and Dunn, Janet A. (2012) The PERSEPHONE trial : duration of trastuzumab with chemotherapy in women with HER2-positive early breast cancer. Journal of Clinical Oncology, 30 (15). doi:10.1200/jco.2012.30.15_suppl.tps660

Balmer, Claire E., Griffiths, Frances and Dunn, Janet A. (2012) Using photovoice to study the experience of living with and beyond the diagnosis of a poor prognostic cancer. BMJ Supportive & Palliative Care, 2 (Suppl_1). A28-A28. doi:10.1136/bmjspcare-2012-000196.82

Abdelaziz, M., Marshall, A. (Andrea)‏, Hussain, K., Bradley, A., Agostini, P., Bishay, E., Kalkat, M., Steyn, R., Rajesh, P., Dunn, Janet A. and Naidu, B. (2012) Can the thoracoscore and revised cardiac risk index predict outcomes? Lung Cancer, 75 (Supplement 1). S63. doi:10.1016/S0169-5002(12)70193-9

Parsons, A., Bradley, A., Reaper, L., Jordan, C., Paul, A., Dowswell, G., Dunn, Janet A. and Naidu, B. (2012) Patient's experiences of a pre and post surgery rehabilitation programme for lung cancer (Rehabilitation Of lung Cancer (ROC) programme) : a qualitative interview study. Lung Cancer, 75 . S64-S64. doi:10.1016/S0169-5002(12)70196-4

(2012) Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer : results with over 7 years median follow-up from the randomised phase III NEAT/BR9601 trials. British Journal of Cancer, Vol.107 (No.8). pp. 1257-1267. doi:10.1038/bjc.2012.370

Poole, Christopher J., Marshall, A. (Andrea)‏, Higgins, Helen B., Fletcher, J., Williams, S. J., Lo, N., Fernando, I. N., Osborne, R., Crawford, S. M., Rafii, S., Gill, S. and Dunn, Janet A. (2012) Neo-escape : Neoadjuvant extended sequential chemotherapy with adjuvant postoperative treatment for epithelial nonmucinous advanced inoperable peritoneal malignancy. Journal of Clinical Oncology, 30 (15). p. 1.

Bradley, A., Marshall, A. (Andrea), Abdelaziz, M., Hussain, K., Agostini, P., Bishay, E., Kalkat, M., Steyn, R., Rajesh, P., Dunn, Janet A. and Naidu, Babu V. (2012) Thoracoscore fails to predict complications following elective lung resection. European Respiratory Journal, Vol.40 (No.6). pp. 1496-1501. doi:10.1183/09031936.00218111

Iqbal, Gulnaz, Johnson, Mark R. D., Szczepura, Ala, Wilson, Sue, Gumber, Anil and Dunn, Janet A. (2012) UK ethnicity data collection for healthcare statistics : the South Asian perspective. BMC Public Health, Vol.12 (No.1). p. 243. doi:10.1186/1471-2458-12-243

Balmer, Claire E., Dunn, Janet A. and Griffiths, Frances (2012) Using photographs to describe what it’s like to live with and beyond cancer. In: INVOLVE 2012 conference, East Midlands Conference Centre, Nottingham, 13-14 Nov 2012

Spooner, David A., Stocken, D. D., Jordan, S., Bathers, S., Dunn, Janet A., Jevons, C., Dodson, L., Morrison, J. M., Oates, G. D. and Grieve, R. J. (2012) A randomised controlled trial to evaluate both the role and the optimal fractionation of radiotherapy in the conservative management of early breast cancer. Clinical Oncology, Vol.24 (No.10). pp. 697-706. doi:10.1016/j.clon.2012.08.003

Tudur Smith, Catrin, Stocken, Deborah D., Dunn, Janet A., Cox, Trevor F., Ghaneh, Paula, Cunningham, David and Neoptolemos, John P. (2012) The value of source data verification in a cancer clinical trial. PLoS ONE , Vol.7 (No.12). e51623. doi:10.1371/journal.pone.0051623

2011

Earl, H. M., Loi, S., Vallier, A. L., Hiller, L., Ogburn-Storey, E., Higgins, H. and Dunn, Janet A. (2011) The PERSEPHONE trial : duration of trastuzumab with chemotherapy in women with HER2 positive early breast cancer. Changing the randomisation point to address potential barriers to recruitment. Cancer Research, 71 (24). doi:10.1158/0008-5472.SABCS11-OT1-02-08

Hiller, Louise, Dunn, Janet A., Higgins, Helen B., Ogburn-Storey, Emma, Loi, Shrushma, Vallier, Anne-Laure and Earl, Helena M. (2011) Optimising patient recall of adverse events over prolonged time periods. Trials, Vol.12 (Suppl.1). A74. doi:10.1186/1745-6215-12-S1-A74

Marshall, A. (Andrea), Dunn, Janet A., Fletcher, Julie, Higgins, Helen B. and Poole, Christopher (2011) The importance of planning for a seamless transition in an adaptive phase II randomised trial. Trials, Vol.12 (Suppl.1). A7. doi:10.1186/1745-6215-12-S1-A7

Campbell, H. E., Epstein, D., Bloomfield, D., Griffin, S., Manca, A., Yarnold, J., Bliss, J., Johnson, L., Earl, Helena M., Poole, Christopher J., Hiller, Louise, Dunn, Janet A., Hopwood, P., Barrett-Lee, P., Ellis, P., Cameron, D., Harris, A. L., Gray, A. M. and Sculpher, Mark J. (2011) The cost-effectiveness of adjuvant chemotherapy for early breast cancer : a comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses. European Journal of Cancer, Vol.47 (No.17). pp. 2517-2530. doi:10.1016/j.ejca.2011.06.019

Ali, A. M. G., Provenzano, E., Abraham, J., Bartlett, J. M., Poole, C. J., Hiller, L., Dunn, Janet A., Twelves, C., Earl, H. M., Caldas, C. and Pharoah, P. (2011) Prognosis by breast cancer subtypes in patients treated with adjuvant chemotherapy in a clinical trial. Journal of Clinical Oncology, 29 (27). doi:10.1200/jco.2011.29.27_suppl.12

Ishak, K. Jack, Caro, J. Jaime, Drayson, Mark T., Dimopoulos, Meletios, Weber, Donna, Augustson, Bradley, Child, J. Anthony, Knight, Robert, Iqbal, Gulnaz, Dunn, Janet A., Shearer, Arran and Morgan, Gareth (2011) Adjusting for patient crossover in clinical trials using external data : a case study of lenalidomide for advanced multiple myeloma. Value in Health, Vol.14 (No.5). pp. 672-678. doi:10.1016/j.jval.2011.02.1182

2010

(2010) Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. Journal of the National Cancer Institute - Monographs, 41 . pp. 162-177. doi:10.1093/jncimonographs/lgq039

Midgley, Rachel S., McConkey, Christopher C., Johnstone, Elaine C., Dunn, Janet A., Smith, Justine L., Grumett, Simon A., Julier, Patrick, Iveson, Claire, Yanagisawa, Yoko, Warren, Bryan, Langman, Michael J. and Kerr, David J. (2010) Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial. Journal of Clinical Oncology, Vol.28 (No.30). pp. 4575-4580. doi:10.1200/JCO.2010.29.6244

Bartlett, John M. S., Munro, Alison F., Dunn, Janet A., McConkey, Christopher C., Jordan, S., Twelves, Chris, Cameron, D., Thomas, Jeremy St. J., Campbell, Fiona M., Rea, Daniel W., Provenzano, Elena, Caldas, Carlos, Pharaoh, Paul, Hiller, Louise, Earl, Helena M. and Poole, Christopher (2010) Predictive markers of anthracycline benefit : a prospectively planned analysis of the UK national epirubicin adjuvant trial (NEAT/BR9601). Lancet Oncology, Vol.11 (No.3). pp. 266-274. doi:10.1016/S1470-2045(10)70006-1

Balmer, Claire E., Dunn, Janet A. and Griffiths, Frances (2010) How does contemporary health care meet the needs of those living with a poor prognostic cancer and does it need improving? In: ESRC Research Methods Conference

Balmer, Claire E., Dunn, Janet A. and Griffiths, Frances (2010) Using photography to find out about the needs of often neglected populations. In: INVOLVE Conference 2010, 2010

2009

Bartlett, J. M. S., Munro, A., Desmedt, Christine, Dunn, Janet A., Larsimont, D., O'Malley, F. P., Cameron, D. A., Earl, Helena M., Poole, Christopher J., Shepherd, Lois, Cardoso, Fatima, Caldas, Carlos, Twelves, Chris, Pritchard, K., Rea, D. W. and di Leo, A. (2009) Duplication of chromosome 17 CEP predicts for anthracycline benefit: a meta-analysis of 4 trials. In: 32nd Annual San Antonio Breast Cancer Symposium, San Antonio, TX, DEC 09-13, 2009. Published in: Cancer Research, Vol.69 (No.24 Suppl. 3). 716S-716S. ISSN 0008-5472. doi:10.1158/0008-5472.SABCS-09-4030

Iqbal, Gulnaz, Gumber, Anil, Johnson, Mark R. D., Szczepura, Ala, Wilson, Sue and Dunn, Janet A. (2009) Improving ethnicity data collection for health statistics in the UK. Diversity in Health and Care, Vol.6 (No.4). pp. 267-285.

(2009) Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer. Journal of Clinical Oncology, Vol.27 (No.33). pp. 5513-5518. doi:10.1200/JCO.2009.24.2446

Morgan, G. J., Knight, R. D., Ishak, K. J., Drayson, M. T., Dimopoulos, M. A., Weber, D. M., Augustson, B., Child, J. A., Begum, G., Dunn, Janet A., Shearer, A. and Caro, J. J. (2009) Addressing biased survival due to crossover in trials. Clinical Lymphoma & Myeloma, 9 (Supplement 1). S50-S51. doi:10.1016/S1557-9190(11)70538-8

Bartlett, J. M. S., Munro, A., Dunn, Janet A., Hiller, Louise, Jordan, S., Twelves, Chris, Cameron, D. A., Thomas, J., Campbell, F., Rea, D. W., Provenzano, E., Pharoah, P., Caldas, Carlos, Earl, Helena M. and Poole, Christopher J. (2009) Chromosome 17 polysomy (Ch17) as a predictor of anthracycline response: emerging evidence from the UK NEA Tadjuvant breast cancer trial. In: 31st Annual San Antonio Breast Cancer Symposium, San Antonio, TX, December 10-14, 2008. Published in: Cancer Research, Vol.69 (No.2 Suppl. S). 74S-74S. ISSN 0008-5472. doi:10.1158/0008-5472.SABCS-45

Spooner, David A., Stocken, D. D., Jordan, S., Bathers, S., Dunn, Janet A., Jevons, C., Morrison, M., Oates, G. and Grieve, R. (2009) A randomised controlled trial to evaluate both the role and optimal fractionation of radiotherapy in the conservative management of early breast cancer. In: 31st Annual San Antonio Breast Cancer Symposium, San Antonio, TX, December 10-14, 2008. Published in: Cancer Research, Vol.69 (No.2 Suppl. S). 338S-338S. ISSN 0008-5472. doi:10.1158/0008-5472.SABCS-5125

Wong, Wai Lup, Nutting, Chris, Dunn, Janet A., Fisher, Sheila, MacLennan, Ken, MacCabe, Chris and Mehanna, Hisham M. (2009) Advanced head and neck cancer: is there a role for fluorodeoxyglucose PET/computed tomography? Nuclear Medicine Communication, Vol.30 (No.1). pp. 2-4. doi:10.1097/MNM.0b013e32831a9aac

Dunn, Janet A., Wilcox, M., Taggart, Frances M., Hulme, Claire, Tritter, Jonathan, Austoker, Joan, Mossman, Jean, Fide, Jane, Balmer, Claire E., Beaver, Kinter and Donnelly, Peter (2009) Involving patients in clinical trial design : the experience of the UK Ibreast early breast cancer follow-up trial. In: Society for Clinical Trials Annual 30th Annual Meeting 2009, Atlanta, Georgia, USA, 2009

2008

Biswas, S., Wrigley, J., East, C., Hern, A., Marshall, A. (Andrea), Dunn, Janet A., Lorigan, P., Middleton, M. (Mark) and Corrie, P. (2008) A randomised trial evaluating Bevacizumab as adjuvant therapy following resection of AJCC stage IIB, IIC and III cutaneous melanoma : an update. ecancermedicalscience, Vol.2 . p. 108. doi:10.3332/ecancer.2008.108

Behalf NEAT Investigators (Including: Earl, Helena M., Hiller, Louise, Dunn, Janet A., Bathers, S., Harvey, P., Stanley, A., Grieve, R. J., Agrawal, R. K., Fernando, I. N., Brunt, A. M., McAdam, K., O'Reilly, S., Rea, D. W., Spooner, David A. and Poole, Christopher). (2008) NEAT : national epirubicin adjuvant trial - toxicity, delivered dose intensity and quality of life. British Journal of Cancer, Vol.99 (No.8). pp. 1226-1231. doi:10.1038/sj.bjc.6604674

Biswas, S., East, C., A'Hern, A., Marshall, A. (Andrea), Dunn, Janet A., Lorigan, Paul, Middleton, M. (Mark) and Corrie, P. (2008) Adjuvant bevacizumab is safe treatment for melanoma patients at high risk of recurrence. In: 33rd European Society for Medical Oncology Congress, Stockholm, Sweden, 12-16 Sept 2008. Published in: Annals of Oncology, Vol.19 (Suppl.8). pp. 245-246. ISSN 0923-7534.

Midgley, Rachel S. J., McConkey, Christopher C., Langman, Michael J., Smith, Justine L., Julier, Patrick, Iveson, Claire, Johnstone, Elaine, Chen, Xiao-he, Dunn, Janet A. and Kerr, David J. (2008) VICTOR : a phase III placebo-controlled trial of rofecoxib in colorectal cancer patients following surgical resection. In: 33rd European Society for Medical Oncology Congress, Stockholm, Sweden, 12-16 Sept 2008. Published in: Annals of Oncology, Vol.19 (No.19 ). p. 1. ISSN 0923-7534.

tAnGo Trial Collaborators (Including: Wardley, A. M., Hiller, Louise, Howard, H. C., Dunn, Janet A., Bowman, A., Coleman, R. E., Fernando, I. N., Ritchie, D. M., Earl, Helena M. and Poole, Christopher J.). (2008) tAnGo : a randomised phase III trial of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy for early breast cancer : a prospective pulmonary, cardiac and hepatic function evaluation. British Journal of Cancer, Vol.99 (No.4). pp. 597-603. doi:10.1038/sj.bjc.6604538

Kerr, David J., Dunn, Janet A., Langman, Michael J., Smith, J. L., Midgley, Rachel S. J., Iveson, Claire and McConkey, Christopher C. (2008) VICTOR : a phase III placebo-controlled trial of rofecoxib in colorectal cancer patients following surgical resection. Journal of Clinical Oncology, Vol.26 (No.15S). p. 4038.

Ishak, K. J., Deniz, B., Drayson, M., Morgan, G. J., Augustson, B. M., Child, J. A., Begum, G., Dunn, Janet A., Shearer, A. and Caro, J. J. (2008) A novel approach to adjust for the impact on survival resulting from patient cross-over from control to experimental treatment in clinical trials. Value in Health, 11 (3). A155-A155. doi:10.1016/S1098-3015(10)70491-5

Ishak, K., Deniz, B., Drayson, Mark T., Morgan, G. J., Augustson, B., Child, A., Begum, Gulnaz, Dunn, Janet A., Shearer, Arran and Caro, J. Jaime (2008) Modeling overall survival in the event of patient cross-over from dexamethasone to lenalidomide in phase III multiple myeloma trials. In: 48th Annual Scientific Meeting of the British-Society-for-Haematology, Glasgow, Scotland, Apr 07-09, 2008. Published in: British Journal of Haematology, Volume 141 (Supplement 1). p. 121. ISSN 0007-1048.

Donnelly, Peter K., Hiller, Louise and Dunn, Janet A. (2008) Need for the iBreast trial – risk adjusted breast cancer follow-up trial. BMJ .

Donnelly, Peter K., Hiller, Louise and Dunn, Janet A. (2008) Follow-up after breast cancer : national randomised controlled trial is needed. British Medical Journal, Vol.336 (No.7642). pp. 461-462. doi:10.1136/bmj.39500.469664.1F

Friede, Tim, Dunn, Janet A. and Stallard, Nigel (2008) Clinical trials in oncology. In: Missailidis, Sotiris, (ed.) Anticancer therapeutics. Oxford ; Hoboken, NJ: Wiley-Blackwell, pp. 365-375. ISBN 9780470723036

Dunn, Janet A., Balmer, Claire E., McConkey, Christopher C., Nutting, Chris, Fisher, Sheila, Wong, Wai Lup, MacLennan, Ken, McCabe, Chris, Hulme, Claire and Mehanna, Hisham M. (2008) PET-NECK : setting up a collaborative clinical trial in a rare disease site. In: Society for Clinical Trials Annual Meeting 2008

2007

Hiller, Louise, Fenwick, N., Vallier, A. L., Dunn, Janet A., Hilborne, S., Jones, L., Abraham, J., Iddawela, M., Caldas, Carlos and Earl, Helena M. (2007) The challenges of using radiological 'tumour response' as an endpoint in Neo-tAnGo: a national neo-adjuvant chemotherapy breast cancer trial. In: 10th Nottingham International Breast Cancer Conference, Nottingham, England, September 18-20, 2007. Published in: European Journal of Cancer Supplements, Vol.5 (No.3). pp. 33-34. ISSN 1359-6349. doi:10.1016/S1359-6349(07)71800-1

Vioxx in Colorectal Cancer Therapy: Definition of Optimal Regime (VICTOR) Trial Group (Including: Kerr, David J., Dunn, Janet A., Langman, Michael J., Smith, Justine L., Midgley, Rachel S. J., Stanley, Andrew, Stokes, Joanne C., Julier, Patrick, Iveson, Claire, Duvvuri, Ravi and McConkey, Christopher C.). (2007) Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer. New England Journal Of Medicine , Vol.357 (No.4). pp. 360-369. doi:10.1056/NEJMoa071841

VICTOR Trial Grp (Including: Kerr, David J., Dunn, Janet A., Langman, Michael J., Smith, Justine L., Midgley, Rachel S. J., Stanley, Andrew, Stokes, Joanne C., Julier, Patrick, Iveson, Claire, Duvvuri, Ravi and McConkey, Christopher C.). (2007) Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer. New England Journal Of Medicine , Vol.357 (No.4). pp. 360-369. doi:10.1056/NEJMoa071841

Drayson, M. T., Augustson, B. M., Begum, G., Dunn, Janet A., Barth, N. J., Davies, F., Morgan, G., Behrens, J., Smith, A. and Child, J. A. (2007) Survival from relapse and the influence of therapy. In: 11th International Myeloma Workshop/4th International Workshop on Wladenestroms Macroglobulinemia, Kos Isl, Greece, June 25-30, 2007. Published in: Haematologica, Vol.92 (No.6 Suppl. 2). p. 173. ISSN 0390-6078.

2006

(2006) Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer. New England Journal of Medicine, Vol.355 (No.18). pp. 1851-1862. doi:10.1056/NEJMoa052084

Wilson, Sue, Dr, Wakelam, Michael J.O., Hobbs, Richard F. D., Ryan, Angela V., Dunn, Janet A., Redman, Val. D., Patrick, Fiona, Colbourne, Lynne and Martin, Ashley (2006) Evaluation of the accuracy of serum MMP-9 as a test for colorectal cancer in a primary care population. BMC Cancer, Vol.6 (No.25). doi:10.1186/1471-2407-6-258

Ryan, Angela V., Wilson, Sue, Dr, Wakelam, Michael J. O., Warmington, Sally A., Dunn, Janet A., Hodgkin, Richard F. D., Martin, Ashley and Ismail, Tariq (2006) A prospective study to assess the value of MMP-9 in improving the appropriateness of urgent referrals for colorectal cancer. BMC Cancer, Vol.6 (No.251). doi:10.1186/1471-2407-6-251

Drayson, M., Begum, G., Basu, S., Makkuni, S., Dunn, Janet A., Barth, N. and Child, J. A. (2006) Effects of paraprotein heavy and light chain types and free light chain load on survival in myeloma : an analysis of patients receiving conventional-dose chemotherapy in Medical Research Council UK multiple myeloma trials. Blood, 108 (6). pp. 2013-2019. doi:10.1182/blood-2006-03-008953

Poole, C. J., Hiller, Louise, Howard, H. C., Loi, Shrushma, Dunn, Janet A., Canney, P., Wardley, A. M., Crown, J. P., Coleman, R. E., Verrill, M. W., Ellis, P. A., Leonard, R. C., Spooner, David A. and Earl, Helena M. (2006) Tolerability of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy in the randomized phase III tAnGo trial for invasive higher risk early stage breast cancer. In: 29th Annual San Antonio Breast Cancer Symposium, San Antonio, TX, DEC 14-17, 2006. Published in: BREAST CANCER RESEARCH AND TREATMENT, 100 (Suppl. 1). S114-S114. ISSN 0167-6806.

2005

Augustson, B. M., Begum, G., Dunn, Janet A., Barth, N. J., Davies, F., Morgan, G., Behrens, J., Smith, A., Child, J. A. and Drayson, M. T. (2005) Early mortality after diagnosis of multiple myeloma: Analysis of patients entered onto the United Kingdom Medical Research Council trials between 1980 and 2002 - Medical Research Council Adult Leukaemia Working Party. Journal of Clinical Oncology, 23 (36). pp. 9219-9226. doi:10.1200/JCO.2005.03.2086

Lovell, R., Dunn, Janet A., Begum, G., Barth, N. J., Plant, T., Moss, P. A., Drayson, M. T. and Pratt, G. (2005) Soluble syndecan-1 level at diagnosis is an independent prognostic factor in multiple myeloma and the extent of fall from diagnosis to plateau predicts for overall survival. British Journal of Haematology, 130 (4). pp. 542-548. doi:10.1111/j.1365-2141.2005.05647.x

Bassi, C., Stocken, D. D., Olah, A., Friess, H., Buckels, J., Hickey, H., Dervenis, C., Dunn, Janet A., Deakin, M., Carter, R., Ghaneh, P., Neoptolemos, J. P. and Büchler, M. W. (2005) Influence of surgical resection and post-operative complications on survival following adjuvant treatment for pancreatic cancer in the ESPAC-1 randomized controlled trial. Digestive Surgery, 22 (5). pp. 353-363. doi:10.1159/000089771

2004

Neoptolemos, J. P., Stocken, D. D., Friess, H., Bassi, C., Dunn, Janet A., Hickey, H., Beger, H., Fernandez-Cruz, L., Dervenis, C., Lacaine, F., Falconi, M., Pederzoli, P., Pap, A., Spooner, D., Kerr, D. J. and Büchler, M. W. (2004) A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. New England Journal Of Medicine , 350 (12). pp. 1200-1210. doi:10.1056/NEJMoa032295

2003

Neoptolemos, J. P., Cunningham, D., Friess, H., Bassi, C., Stocken, D. D., Tait, D. M., Dunn, Janet A., Dervenis, C., Lacaine, F., Hickey, H., Raraty, M. G. T., Ghaneh, P. and Büchler, M. W. (2003) Adjuvant therapy in pancreatic cancer : historical and current perspectives. Annals of Oncology, 14 (5). pp. 675-692. doi:10.1093/annonc/mdg207

Neoptolemos, J. P., Raraty, M. G. T., Ghaneh, P., Hickey, H., Stocken, D. D., Dunn, Janet A., Friess, H., Buchler, M. W. and Schemmer, P. (2003) Adjuvant and additive therapy for cancer of the pancreas. Der Chirurg, 74 (3). pp. 191-201. doi:10.1007/s00104-003-0614-x

2002

Neoptolemos, J. P., Stocken, D. and Dunn, Janet A. (2002) Letter to the editor 2 (multiple letters). Annals of Surgery, 236 (5). pp. 696-697.

Wallace, D. M. A., Bryan, R. T., Dunn, Janet A., Begum, G. and Bathers, S. (2002) Delay and survival in bladder cancer. BJU International, 89 (9). pp. 868-878. doi:10.1046/j.1464-410X.2002.02776.x

McCloskey, E. V., Dunn, Janet A., Kanis, J. A., MacLennan, I. C. M. and Drayson, M. T. (2002) Long-term follow-up of a prospective, double-blind, placebo-controlled randomized trial of clodronate in multiple myeloma. British Journal of Haematology, 113 (4). pp. 1035-1043. doi:10.1046/j.1365-2141.2001.02851.x

2001

(2001) Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Annals of Surgery, 234 (6). pp. 758-768. doi:10.1097/00000658-200112000-00007

Young, Annie M., Marsden, J., Goodman, A., Burton, Andrea and Dunn, Janet A. (2001) Prospective randomized comparison of dacarbazine (DTIC) versus DTIC plus interferon-alpha (IFN-α) in metastatic melanoma. Clinical Oncology, 13 (6). pp. 458-465. doi:10.1053/clon.2001.9314

Neoptolemos, J. P., Dunn, Janet A., Stocken, D. D., Almond, J., Link, K., Beger, H., Bassi, C., Falconi, M., Pederzoli, P., Dervenis, C., Fernandez-Cruz, L., Lacaine, F., Pap, A., Spooner, D., Kerr, D. J., Friess, H. and Büchler, M. W. (2001) Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer : a randomised controlled trial. Lancet, 358 (9293). pp. 1576-1585. doi:10.1016/S0140-6736(01)06651-X

2000

Herod, J., Burton, A., Buxton, J., Tobias, J., Luesley, D., Jordan, S., Dunn, Janet A. and Poole, C. J. (2000) A randomised, prospective, phase III clinical trial of primary bleomycin, ifosfamide and cisplatin (BIP) chemotherapy followed by radiotherapy versus radiotherapy alone in inoperable cancer of the cervix. Annals of Oncology, 11 (9). pp. 1175-1181. doi:10.1023/A:1008346901733

Cooke, P. W., Dunn, Janet A., Latief, T., Bathers, S., James, N. D. and Wallace, D. M. A. (2000) Long-term risk of salvage cystectomy after radiotherapy for muscle- invasive bladder cancer. European Urology, 38 (3). pp. 279-286. doi:10.1159/000020294

1999

Langman, M. J. S., Dunn, Janet A., Whiting, J. L., Burton, A., Hallissey, M. T., Fielding, J. W. L. and Kerr, D. J. (1999) Prospective, double-blind, placebo-controlled randomized trial of cimetidine in gastric cancer. British Journal of Cancer, 81 (8). pp. 1356-1362. doi:10.1038/sj.bjc.6690457

1998

Drayson, M. T., Chapman, C. E., Olujohungbe, A., Dunn, Janet A. and Maclennan, I. C. M. (1998) The MRC randomised trial of the use of α2b-interferon in first plateau phase in multiple myeloma. Cancer Research Therapy and Control, 6 (1-4). p. 127.

Bailey, N. P., Stuart, N. S. A., Bessell, E. M., Child, J. A., Norfolk, D., Fletcher, J., Grieve, R. J., Simmons, A. V., Barnard, D. L., Jack, A., Farish, J., Dunn, Janet A., Woodroffe, C. M., Stack, C. and Cullen, M. H. (1998) Five-year follow-up of a prospective randomised multi-centre trial of weekly chemotherapy (CAPOMET) versus cyclical chemotherapy (CHOP-Mtx) in the treatment of aggressive non-Hodgkin's lymphoma. Annals of Oncology, 9 (6). pp. 633-638. doi:10.1023/A:1008276700860

McCloskey, E. V., Maclennan, I. C. M., Drayson, M. T., Chapman, C., Dunn, Janet A. and Kanis, J. A. (1998) A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma. British Journal of Haematology, 100 (2). pp. 317-325. doi:10.1046/j.1365-2141.1998.00567.x

Etherington, L. J., Luesley, D. M., Shafi, M. I., Dunn, Janet A. and Jordan, J. A. (1998) Cytological prediction of cervical intraepithelial neoplasia grade 3 : does size of the lesion matter? Journal of Lower Genital Tract Disease, 2 (1). pp. 17-18. doi:10.1097/00128360-199801000-00004

Phillips, L., Lindley, D. V., Longford, N. T., Newby, M. J., Smith, T. M. F., Barnard, G. A., Cox, D. R., Leonard, T., Abdullah, S., Garthwaite, P., Abrams, K. R., Dunn, Janet A., Black, P. K., Blyth, S., Brown, P. J., Dickey, J. M., Flournoy, N. and Smith, J. Q. (1998) Discussion on the papers on 'Elicitation'. Journal Of The Royal Statistical Society Series D -The Statistician, 47 (1). pp. 55-68.

Drayson, M. T., Chapman, C. E., Dunn, Janet A., Olujohungbe, A. B. and Maclennan, I. C. M. (1998) MRC trial of α2b-interferon maintenance therapy in first plateau phase of multiple myeloma. British Journal of Haematology, 101 (1). pp. 195-202. doi:10.1046/j.1365-2141.1998.00648.x

Whiting, J. L., Hallissey, M. T., Fielding, J. W. L. and Dunn, Janet A. (1998) Screening for gastric cancer by Helicobacter pylori serology : a retrospective study. British Journal of Surgery, 85 (3). pp. 408-411. doi:10.1046/j.1365-2168.1998.00581.x

1997

Etherington, I. J., Luesley, D. M., Shafi, M. I., Dunn, Janet A., Hiller, Louise and Jordan, J. A. (1997) Observer variability among colposcopists from the West Midlands region. BJOG: An International Journal of Obstetrics and Gynaecology, 104 (12). pp. 1380-1384. doi:10.1111/j.1471-0528.1997.tb11007.x

Shafi, M. I., Luesley, D. M., Jordan, J. A., Dunn, Janet A., Rollason, T. P. and Yates, M. (1997) Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. BJOG: An International Journal of Obstetrics and Gynaecology, 104 (5). pp. 590-594. doi:10.1111/j.1471-0528.1997.tb11538.x

Etherington, I. J., Dunn, Janet A., Shafi, M. I., Smith, T. and Luesley, D. M. (1997) Video colpography : a new technique for secondary cervical screening. BJOG: An International Journal of Obstetrics and Gynaecology, 104 (2). pp. 150-153. doi:10.1111/j.1471-0528.1997.tb11035.x

Fielding, J. W. L., Dunn, Janet A., Baker, P. G., Davis, J. G., Billingham, L. J., Hallisey, M. T. and Langham, M. J. (1997) An interim report of the cimetidine therapy in stomach cancer (CIS) study. In: UNSPECIFIED. Published in: GI Cancer, 2 (2). p. 175.

1996

Van Geene, P., Varma, R., Dunn, Janet A., Chan, K. K. and Luesley, D. M. (1996) The prognostic significance of intraperitoneal growth characteristics in epithelial ovarian carcinoma. International Journal of Gynecological Cancer, 6 (3). pp. 219-224. doi:10.1046/j.1525-1438.1996.06030219.x

Bramhall, S. R., Stamp, G. W. H., Dunn, Janet A., Lemoine, N. R. and Neoptolemos, J. P. (1996) Expression of collagenase (MMP2), stromelysin (MMP3) and tissue inhibitor of the metalloproteinases (TIMP1) in pancreatic and ampullary disease. British Journal of Cancer, 73 (8). pp. 972-978. doi:10.1038/bjc.1996.190

Priestman, T. J., Dunn, Janet A., Brada, M., Rampling, R. and Baker, P. G. (1996) Final results of the Royal College of Radiologists' Trial comparing two different radiotherapy schedules in the treatment of cerebral metastases. Clinical Oncology, 8 (5). pp. 308-315. doi:10.1016/S0936-6555(05)80717-4

1995

Liu, B., Earl, H. M., Poole, C. J., Dunn, Janet A. and Kerr, D. J. (1995) Etoposide protein binding in cancer patients. Cancer Chemotherapy and Pharmacology, 36 (6). pp. 506-512. doi:10.1007/BF00685801

Yu, C. C. W., Levison, D. A., Dunn, Janet A., Ward, L. C., Demonakou, M., Allum, W. H. and Hallisey, M. T. (1995) Pathological prognostic factors in the second British Stomach Cancer Group trial of adjuvant therapy in resectable gastric cancer. British Journal of Cancer, 71 (5). pp. 1106-1110. doi:10.1038/bjc.1995.214

Clinton, O. P., Priestman, T. J., Latief, T. N., Earl, H., Murphy, A., Blackledge, G. R. P., Dunn, Janet A. and Baker, P. (1995) A prospective randomized trial to evaluate different oral dose regimens of medroxyprogesterone acetate in women with advanced breast cancer. Clinical Oncology, 7 (4). pp. 251-256. doi:10.1016/S0936-6555(05)80614-4

1994

Lynch, T. H., Waymont, B., Dunn, Janet A., Hughes, M. A. and Wallace, D. M. A. (1994) Repeat testing for haematuria and underlying urological pathology. British Journal of Urology, 74 (6). pp. 730-732. doi:10.1111/j.1464-410X.1994.tb07115.x

Silverman, D. T., Dunn, Janet A., Hoover, R. N., Schiffiman, M., Lillemoe, K. D., Schoenberg, J. B., Brown, L. M., Greenberg, R. S., Hayes, R. B., Swanson, G. M., Wacholder, S., Schwartz, A. G., Liff, J. M. and Pottern, L. M. (1994) Cigarette smoking and pancreas cancer : a case-control study based on direct interviews. Journal of the National Cancer Institute, 86 (20). pp. 1510-1516. doi:10.1093/jnci/86.20.1510

Dunn, Janet A. (1994) Seventeenth sir peter freyer memorial lecture and surgical symposium - September 18th & 19th, 1992. Irish Journal of Medical Science, 163 (1). pp. 68-92. doi:10.1007/BF02943019

Hallissey, M. T., Dunn, Janet A., Ward, L. C. and Allum, W. H. (1994) The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer : five-year follow-up. The Lancet, 343 (8909). pp. 1309-1312. doi:10.1016/S0140-6736(94)92464-3

Shafi, M. I., Dunn, Janet A., Chenoy, R., Buxton, E. J., Williams, C. and Luesley, D. M. (1994) Digital imaging colposcopy, image analysis and quantification of the colposcopic image. BJOG: An International Journal of Obstetrics & Gynaecology, 101 (3). pp. 234-238. doi:10.1111/j.1471-0528.1994.tb13116.x

Lynch, T. H., Waymont, B., Dunn, Janet A., Hughes, M. A. and Wallace, D. M. A. (1994) Rapid diagnostic service for patients with haematuria. British Journal of Urology, 73 (2). pp. 147-151. doi:10.1111/j.1464-410X.1994.tb07482.x

Luesley, D., Blomfield, P., Dunn, Janet A., Shafi, M., Chenoy, R. and Buxton, J. (1994) Cigarette smoking and histological outcome in wom with mildly dyskaryotic cervical smears. BJOG: An International Journal of Obstetrics & Gynaecology, 101 (1). pp. 49-52. doi:10.1111/j.1471-0528.1994.tb13009.x

Hutchinson, R., Tyrrell, P. N. M., Kumar, D., Dunn, Janet A., Li, J. K. W. and Allan, R. N. (1994) Pathogenesis of gall stones in Crohn's disease : an alternative explanation. Gut, 35 (1). pp. 94-97. doi:10.1136/gut.35.1.94

Maclennan, I. C. M., Drayson, M. and Dunn, Janet A. (1994) Current issues in cancer : multiple myeloma. BMJ Open, 308 (6935). pp. 1033-1036. doi:10.1136/bmj.308.6935.1033

Hallissey, M. T., Dunn, Janet A. and Fielding, J. W. L. (1994) Evaluation of pepsinogen a and gastrin-17 as markers of gastric cancer and high-risk pathologic conditions. Scandinavian Journal of Gastroenterology, 29 (12). pp. 1129-1134. doi:10.3109/00365529409094899

Stonelake, P. S., Bundred, N. J., Neoptolemos, N. P., Baker, P. R., Baker, P. G., Gillespie, W. M., Dunn, Janet A., Spooner, D., Morrison, J. M., Bundred, N. J., Oates, G. D., Stonelake, P. S., Lee, M. J. R., Neoptolemos, J. P. and Chan, S. Y. (1994) Steroid receptors, pS2 and cathepsin D in early clinically node-negative breast cancer. European Journal of Cancer Care, 30 (1). pp. 5-11. doi:10.1016/S0959-8049(05)80008-5

1993

Hallissey, M. T., Jewkes, A. J., Dunn, Janet A., Ward, L. and Fielding, J. W. L. (1993) Resection‐line involvement in gastric cancer : a continuing problem. British Journal of Surgery, 80 (11). pp. 1418-1420. doi:10.1002/bjs.1800801121

Blomfield, P. I., Buxton, J., Dunn, Janet A. and Luesley, D. M. (1993) Pregnancy outcome after large loop excision of the cervical transformation zone. American Journal of Obstetrics and Gynecology, 169 (3). pp. 620-625. doi:10.1016/0002-9378(93)90633-T

Deakin, M., Gunson, B. K., Dunn, Janet A., McMaster, P., Tisone, G., Warwick, Jane and Buckels, J. A. (1993) Factors influencing blood transfusion during adult liver transplantation. Annals of The Royal College of Surgeons of England, 75 (5). pp. 339-344.

Stonelake, P. S., Powell, J., Dunn, Janet A., Warwick, Jane, Bramhall, S. R., Neoptolemos, J. P., Baker, P. R. and Morrison, J. M. (1993) Influence of timing of surgery during menstrual, cycle on survival of premenopausal women with operable breast cancer. The Breast, Volume 2 (Number 3). pp. 201-202. doi:10.1016/0960-9776(93)90130-8

Finn, C. B., Dunn, Janet A., Buxton, E. J., Luesley, D. M. and Shafi, M. (1993) Can we predict a high risk group in ovarian cancer? International Journal of Gynecological Cancer, 3 (4). pp. 226-230. doi:10.1046/j.1525-1438.1993.03040226.x

Shafi, M. I., Dunn, Janet A., Finn, C. B., Kehoe, S., Buxton, E. J., Jordan, J. A. and Luesley, D. M. (1993) Characterization of high- and low-grade cervical intraepithelial neoplasia. International Journal of Gynecological Cancer, 3 (4). pp. 203-207. doi:10.1046/j.1525-1438.1993.03040203.x

Brown, R. D., Joshua, D. E., Nelson, M., Gibson, J., Dunn, Janet A. and MacLennan, I. C. M. (1993) Serum thymidine kinase as a prognostic indicator for patients with multiple myeloma : results from the MRC (UK) V Trial. British Journal of Haematology, 84 (2). pp. 238-241. doi:10.1111/j.1365-2141.1993.tb03058.x

Waymont, B., Lynch, T. H., Dunn, Janet A., Bathers, S. and Wallace, D. M. A. (1993) Treatment Preferences of urologists in Great Britain and Ireland in the management of prostate cancer. British Journal of Urology, 71 (5). pp. 577-582. doi:10.1111/j.1464-410X.1993.tb16028.x

de Takats, P. G., Dunn, Janet A., Kerr, D. J. and Morrison, J. M. (1993) Impact of adjuvant chemotherapy in breast cancer on response to tamoxifen at relapse. Cancer Treatment Reviews, 19 (Supplement B). pp. 11-19. doi:10.1016/0305-7372(93)90003-A

Shafi, M. I., Dunn, Janet A., Buxton, E. J., Finn, C. B., Jordan, J. A. and Luesley, D. M. (1993) Abnormal cervical cytology following large loop excision of the transformation zone : a case controlled study. Obstetrical and Gynecological Survey, 48 (8). pp. 546-548. doi:10.1111/j.1471-0528.1993.tb15210.x

Wallace, L. M., Priestman, S. G., Dunn, Janet A. and Priestman, T. J. (1993) The quality of life of early breast cancer patients treated by two different radiotherapy regimens. Clinical Oncology, 5 (4). pp. 228-233. doi:10.1016/S0936-6555(05)80234-1

1992

Lynch, T. H., Waymont, B., Dunn, Janet A. and Wallace, D. M. A. (1992) Urologists' attitudes to the management of bladder cancer. British Journal of Urology, 70 (5). pp. 522-525. doi:10.1111/bju.1992.70.5.522

Ward, L. C., Fielding, J. W. L. and Dunn, Janet A. (1992) The selection of cases for randomised trials : a registry survey of concurrent trial and non-trial patients. British Journal of Cancer, 66 (5). pp. 943-950. doi:10.1038/bjc.1992.390

Dunn, Janet A. and MacLennan, I. (1992) Comparing trials for the treatment of myelomatosis. Controlled Clinical Trials, 13 (5). p. 441. doi:10.1016/0197-2456(92)90198-9

Dunn, Janet A. and Hallissey, M. T. (1992) Developing a prognostic index for stomach cancer. Controlled Clinical Trials, 13 (5). p. 427. doi:10.1016/0197-2456(92)90163-T

Finn, C. B., Luesley, D. M., Buxton, E. J., Blackledge, G. R., Kelly, K., Dunn, Janet A. and Wilson, S. (1992) Is stage I epithelial ovarian cancer over-treated both surgically and systematically? Results of a five-year cancer registry review. Obstetrical and Gynecological Survey, 47 (7). pp. 491-493. doi:10.1016/0197-2456(92)90198-9

Dunn, Janet A. (1992) Prognostic indices : who needs them? Controlled Clinical Trials, 13 (5). pp. 381-382. doi:10.1016/0197-2456(92)90053-3

Clarke, M., Gray, R., Dunn, Janet A. and Maclennan, I. (1992) Combination chemotherapy for myelomatosis. The Lancet, 340 (8816). p. 433. doi:10.1016/0140-6736(92)91520-I

Oláh, K. S., Dunn, Janet A. and Gee, H. (1992) Leiomyosarcomas have a poorer prognosis than mixed mesodermal tumours when adjusting for known prognostic factors : the result of a retrospective study of 423 cases of uterine sarcoma. BJOG: An International Journal of Obstetrics & Gynaecology, 99 (7). pp. 590-594. doi:10.1111/j.1471-0528.1992.tb13827.x

Waymont, B., Lynch, T. H., Dunn, Janet A., Emtage, L. A., Arkell, D. G., Wallace, D. M. A. and Blackledge, G. R. P. (1992) Phase III randomised study of Zoladex versus Stilboestrol in the treatment of advanced prostate cancer. British Journal of Urology, 69 (6). pp. 614-620. doi:10.1111/j.1464-410X.1992.tb15633.x

The Medical Research Council Working Party For Leukæmia In Adults (Including: MacLennan, I. C. M., Chapman, C., Dunn, Janet A. and Kelly, K.). (1992) Combined chemotherapy with ABCM versus melphalan for treatment of myelomatosis. The Lancet, 339 (8787). pp. 200-205. doi:10.1016/0140-6736(92)90004-M

Finn, Catherine B., Luesley, D. M., Buxton, E. J., Blackledge, G. R., Kelly, K., Dunn, Janet A. and Wilson, S. (1992) Is Stage I epithelial ovarian cancer overtreated both surgically and systemically? Results of a five-year cancer registry review. BJOG: An International Journal of Obstetrics and Gynaecology, 99 (1). pp. 54-58. doi:10.1111/j.1471-0528.1992.tb14393.x

1991

Oláh, K. S., Gee, H., Blunt, S., Dunn, Janet A., Kelly, K. and Chan, K. K. (1991) Retrospective analysis of 318 cases of uterine sarcoma. European Journal of Cancer and Clinical Oncology, 27 (9). pp. 1095-1099. doi:10.1016/0277-5379(91)90300-3

Finn, C. B., Ward, K., Luesley, D. M., Dunn, Janet A. and Redman, C. W. E. (1991) Qualitative and quantitative analysis of peritoneal fluids from women with gynecologic diseases. Comparison of cytology and flow cytometry for the detection of malignancy in lavage and ascitic fluids. Analytical and Quantitative Cytology and Histology, 13 (3). pp. 182-186.

Shafi, M. I., Finn, C. B., Luesley, D. M., Jordan, J. A. and Dunn, Janet A. (1991) Lesion size and histology of atypical cervical transformation zone. BJOG: An International Journal of Obstetrics & Gynaecology, 98 (5). pp. 490-492. doi:10.1111/j.1471-0528.1991.tb10349.x

Lynch, T. H., Waymont, B., Beacock, C. J. M., Dunn, Janet A., Hughes, M. A. and Wallace, D. M. A. (1991) Follow up after transurethral resection of prostate : who needs it? British Medical Journal, 302 (6767). p. 27. doi:10.1136/bmj.302.6767.27

1990

Wallace, D. M. A., Raghavan, D., Kelly, K. A., Sandeman, T. F., Conn, I. G., Teriana, N., Dunn, Janet A., Boulas, J. and Latief, T. (1990) Neo‐adjuvant (pre‐emptive) Cisplatin therapy in invasive transitional cell carcinoma of the bladder. British Journal of Urology, 67 (6). pp. 608-615. doi:10.1111/j.1464-410X.1991.tb15225.x

Berisa, F., Beaman, M., Adu, D., McGonigle, R. J. S., Michael, J., Downing, R., Fielding, J. W. L. and Dunn, Janet A. (1990) Prognostic factors in acute renal failure following aortic aneurysm surgery. QJM, 76 (1). pp. 689-698. doi:10.1093/oxfordjournals.qjmed.a068475

Valori, R. M., Hallisey, M. T. and Dunn, Janet A. (1990) Power of oesophageal peristalsis can be controlled voluntarily. Gut, 32 (3). pp. 236-239. doi:10.1136/gut.32.3.236